0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Lumbosacral Radicular Pain Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: April 2024
|
Report Code: QYRE-Auto-8B14288
Home | Market Reports | Health| Health Conditions| Pain Management
Global Lumbosacral Radicular Pain Treatment Market Research Report 2023
BUY CHAPTERS

Lumbosacral Radicular Pain Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-8B14288
Report
April 2024
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lumbosacral Radicular Pain Treatment - Market Size

The global market for Lumbosacral Radicular Pain Treatment was estimated to be worth US$ 857 million in 2023 and is forecast to a readjusted size of US$ 1206.1 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030

Lumbosacral Radicular Pain Treatment - Market

Lumbosacral Radicular Pain Treatment - Market

Lumbosacral radicular pain is a type of pain that originates from the lower back and radiates down the leg, typically caused by compression or irritation of the spinal nerves.
Lumbosacral radicular pain is a type of pain that originates from the lower back and radiates down the leg, typically caused by compression or irritation of the spinal nerves. The treatment of lumbosacral radicular pain typically involves a combination of pharmacological and non-pharmacological interventions.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lumbosacral Radicular Pain Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Lumbosacral Radicular Pain Treatment by region & country, by Type, and by Application.
The Lumbosacral Radicular Pain Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lumbosacral Radicular Pain Treatment.
Market Segmentation

Scope of Lumbosacral Radicular Pain Treatment - Market Report

Report Metric Details
Report Name Lumbosacral Radicular Pain Treatment - Market
Forecasted market size in 2030 US$ 1206.1 million
CAGR 5.0%
Forecasted years 2024 - 2030
Segment by Type:
  • Oral
  • Topical
Segment by Application
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Competition Deep Dive, Semnur Pharmaceuticals, Inc., Eliem Therapeutics, Forest Laboratories, Medtronic Spinal and Biologics, Teva Pharmaceutical, 3M Company, Ultradent Products Inc., Nobel Biocare Holdings AG, Eli Lilly & Company
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Lumbosacral Radicular Pain Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Lumbosacral Radicular Pain Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Lumbosacral Radicular Pain Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Lumbosacral Radicular Pain Treatment - Market size in 2030?

Ans: The Lumbosacral Radicular Pain Treatment - Market size in 2030 will be US$ 1206.1 million.

Who are the main players in the Lumbosacral Radicular Pain Treatment - Market report?

Ans: The main players in the Lumbosacral Radicular Pain Treatment - Market are Competition Deep Dive, Semnur Pharmaceuticals, Inc., Eliem Therapeutics, Forest Laboratories, Medtronic Spinal and Biologics, Teva Pharmaceutical, 3M Company, Ultradent Products Inc., Nobel Biocare Holdings AG, Eli Lilly & Company

What are the Application segmentation covered in the Lumbosacral Radicular Pain Treatment - Market report?

Ans: The Applications covered in the Lumbosacral Radicular Pain Treatment - Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Lumbosacral Radicular Pain Treatment - Market report?

Ans: The Types covered in the Lumbosacral Radicular Pain Treatment - Market report are Oral, Topical

1 Market Overview
1.1 Lumbosacral Radicular Pain Treatment Product Introduction
1.2 Global Lumbosacral Radicular Pain Treatment Market Size Forecast
1.3 Lumbosacral Radicular Pain Treatment Market Trends & Drivers
1.3.1 Lumbosacral Radicular Pain Treatment Industry Trends
1.3.2 Lumbosacral Radicular Pain Treatment Market Drivers & Opportunity
1.3.3 Lumbosacral Radicular Pain Treatment Market Challenges
1.3.4 Lumbosacral Radicular Pain Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Lumbosacral Radicular Pain Treatment Players Revenue Ranking (2023)
2.2 Global Lumbosacral Radicular Pain Treatment Revenue by Company (2019-2024)
2.3 Key Companies Lumbosacral Radicular Pain Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Lumbosacral Radicular Pain Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Lumbosacral Radicular Pain Treatment
2.6 Lumbosacral Radicular Pain Treatment Market Competitive Analysis
2.6.1 Lumbosacral Radicular Pain Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Lumbosacral Radicular Pain Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lumbosacral Radicular Pain Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral
3.1.2 Topical
3.2 Global Lumbosacral Radicular Pain Treatment Sales Value by Type
3.2.1 Global Lumbosacral Radicular Pain Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Lumbosacral Radicular Pain Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Lumbosacral Radicular Pain Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Online Pharmacy
4.2 Global Lumbosacral Radicular Pain Treatment Sales Value by Application
4.2.1 Global Lumbosacral Radicular Pain Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Lumbosacral Radicular Pain Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Lumbosacral Radicular Pain Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Lumbosacral Radicular Pain Treatment Sales Value by Region
5.1.1 Global Lumbosacral Radicular Pain Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Lumbosacral Radicular Pain Treatment Sales Value by Region (2019-2024)
5.1.3 Global Lumbosacral Radicular Pain Treatment Sales Value by Region (2025-2030)
5.1.4 Global Lumbosacral Radicular Pain Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030
5.2.2 North America Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030
5.3.2 Europe Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030
5.5.2 South America Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Lumbosacral Radicular Pain Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Lumbosacral Radicular Pain Treatment Sales Value
6.3 United States
6.3.1 United States Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030
6.3.2 United States Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Lumbosacral Radicular Pain Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030
6.4.2 Europe Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Lumbosacral Radicular Pain Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030
6.5.2 China Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Lumbosacral Radicular Pain Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030
6.6.2 Japan Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Lumbosacral Radicular Pain Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030
6.7.2 South Korea Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Lumbosacral Radicular Pain Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Lumbosacral Radicular Pain Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030
6.9.2 India Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Lumbosacral Radicular Pain Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Competition Deep Dive
7.1.1 Competition Deep Dive Profile
7.1.2 Competition Deep Dive Main Business
7.1.3 Competition Deep Dive Lumbosacral Radicular Pain Treatment Products, Services and Solutions
7.1.4 Competition Deep Dive Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Competition Deep Dive Recent Developments
7.2 Semnur Pharmaceuticals, Inc.
7.2.1 Semnur Pharmaceuticals, Inc. Profile
7.2.2 Semnur Pharmaceuticals, Inc. Main Business
7.2.3 Semnur Pharmaceuticals, Inc. Lumbosacral Radicular Pain Treatment Products, Services and Solutions
7.2.4 Semnur Pharmaceuticals, Inc. Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Semnur Pharmaceuticals, Inc. Recent Developments
7.3 Eliem Therapeutics
7.3.1 Eliem Therapeutics Profile
7.3.2 Eliem Therapeutics Main Business
7.3.3 Eliem Therapeutics Lumbosacral Radicular Pain Treatment Products, Services and Solutions
7.3.4 Eliem Therapeutics Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Forest Laboratories Recent Developments
7.4 Forest Laboratories
7.4.1 Forest Laboratories Profile
7.4.2 Forest Laboratories Main Business
7.4.3 Forest Laboratories Lumbosacral Radicular Pain Treatment Products, Services and Solutions
7.4.4 Forest Laboratories Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Forest Laboratories Recent Developments
7.5 Medtronic Spinal and Biologics
7.5.1 Medtronic Spinal and Biologics Profile
7.5.2 Medtronic Spinal and Biologics Main Business
7.5.3 Medtronic Spinal and Biologics Lumbosacral Radicular Pain Treatment Products, Services and Solutions
7.5.4 Medtronic Spinal and Biologics Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Medtronic Spinal and Biologics Recent Developments
7.6 Teva Pharmaceutical
7.6.1 Teva Pharmaceutical Profile
7.6.2 Teva Pharmaceutical Main Business
7.6.3 Teva Pharmaceutical Lumbosacral Radicular Pain Treatment Products, Services and Solutions
7.6.4 Teva Pharmaceutical Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Teva Pharmaceutical Recent Developments
7.7 3M Company
7.7.1 3M Company Profile
7.7.2 3M Company Main Business
7.7.3 3M Company Lumbosacral Radicular Pain Treatment Products, Services and Solutions
7.7.4 3M Company Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 3M Company Recent Developments
7.8 Ultradent Products Inc.
7.8.1 Ultradent Products Inc. Profile
7.8.2 Ultradent Products Inc. Main Business
7.8.3 Ultradent Products Inc. Lumbosacral Radicular Pain Treatment Products, Services and Solutions
7.8.4 Ultradent Products Inc. Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Ultradent Products Inc. Recent Developments
7.9 Nobel Biocare Holdings AG
7.9.1 Nobel Biocare Holdings AG Profile
7.9.2 Nobel Biocare Holdings AG Main Business
7.9.3 Nobel Biocare Holdings AG Lumbosacral Radicular Pain Treatment Products, Services and Solutions
7.9.4 Nobel Biocare Holdings AG Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Nobel Biocare Holdings AG Recent Developments
7.10 Eli Lilly & Company
7.10.1 Eli Lilly & Company Profile
7.10.2 Eli Lilly & Company Main Business
7.10.3 Eli Lilly & Company Lumbosacral Radicular Pain Treatment Products, Services and Solutions
7.10.4 Eli Lilly & Company Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 Eli Lilly & Company Recent Developments
8 Industry Chain Analysis
8.1 Lumbosacral Radicular Pain Treatment Industrial Chain
8.2 Lumbosacral Radicular Pain Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Lumbosacral Radicular Pain Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Lumbosacral Radicular Pain Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Lumbosacral Radicular Pain Treatment Market Trends
    Table 2. Lumbosacral Radicular Pain Treatment Market Drivers & Opportunity
    Table 3. Lumbosacral Radicular Pain Treatment Market Challenges
    Table 4. Lumbosacral Radicular Pain Treatment Market Restraints
    Table 5. Global Lumbosacral Radicular Pain Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Lumbosacral Radicular Pain Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Lumbosacral Radicular Pain Treatment Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Lumbosacral Radicular Pain Treatment Product Type
    Table 9. Key Companies Time to Begin Mass Production of Lumbosacral Radicular Pain Treatment
    Table 10. Global Lumbosacral Radicular Pain Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lumbosacral Radicular Pain Treatment as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Lumbosacral Radicular Pain Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Lumbosacral Radicular Pain Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Lumbosacral Radicular Pain Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Lumbosacral Radicular Pain Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Lumbosacral Radicular Pain Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Lumbosacral Radicular Pain Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Lumbosacral Radicular Pain Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Lumbosacral Radicular Pain Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Lumbosacral Radicular Pain Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Lumbosacral Radicular Pain Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Lumbosacral Radicular Pain Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Lumbosacral Radicular Pain Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Lumbosacral Radicular Pain Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Lumbosacral Radicular Pain Treatment Sales Value by Region (2019-2024) & (%)
    Table 27. Global Lumbosacral Radicular Pain Treatment Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Lumbosacral Radicular Pain Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Lumbosacral Radicular Pain Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Lumbosacral Radicular Pain Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 31. Competition Deep Dive Basic Information List
    Table 32. Competition Deep Dive Description and Business Overview
    Table 33. Competition Deep Dive Lumbosacral Radicular Pain Treatment Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of Competition Deep Dive (2019-2024)
    Table 35. Competition Deep Dive Recent Developments
    Table 36. Semnur Pharmaceuticals, Inc. Basic Information List
    Table 37. Semnur Pharmaceuticals, Inc. Description and Business Overview
    Table 38. Semnur Pharmaceuticals, Inc. Lumbosacral Radicular Pain Treatment Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of Semnur Pharmaceuticals, Inc. (2019-2024)
    Table 40. Semnur Pharmaceuticals, Inc. Recent Developments
    Table 41. Eliem Therapeutics Basic Information List
    Table 42. Eliem Therapeutics Description and Business Overview
    Table 43. Eliem Therapeutics Lumbosacral Radicular Pain Treatment Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of Eliem Therapeutics (2019-2024)
    Table 45. Eliem Therapeutics Recent Developments
    Table 46. Forest Laboratories Basic Information List
    Table 47. Forest Laboratories Description and Business Overview
    Table 48. Forest Laboratories Lumbosacral Radicular Pain Treatment Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of Forest Laboratories (2019-2024)
    Table 50. Forest Laboratories Recent Developments
    Table 51. Medtronic Spinal and Biologics Basic Information List
    Table 52. Medtronic Spinal and Biologics Description and Business Overview
    Table 53. Medtronic Spinal and Biologics Lumbosacral Radicular Pain Treatment Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of Medtronic Spinal and Biologics (2019-2024)
    Table 55. Medtronic Spinal and Biologics Recent Developments
    Table 56. Teva Pharmaceutical Basic Information List
    Table 57. Teva Pharmaceutical Description and Business Overview
    Table 58. Teva Pharmaceutical Lumbosacral Radicular Pain Treatment Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of Teva Pharmaceutical (2019-2024)
    Table 60. Teva Pharmaceutical Recent Developments
    Table 61. 3M Company Basic Information List
    Table 62. 3M Company Description and Business Overview
    Table 63. 3M Company Lumbosacral Radicular Pain Treatment Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of 3M Company (2019-2024)
    Table 65. 3M Company Recent Developments
    Table 66. Ultradent Products Inc. Basic Information List
    Table 67. Ultradent Products Inc. Description and Business Overview
    Table 68. Ultradent Products Inc. Lumbosacral Radicular Pain Treatment Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of Ultradent Products Inc. (2019-2024)
    Table 70. Ultradent Products Inc. Recent Developments
    Table 71. Nobel Biocare Holdings AG Basic Information List
    Table 72. Nobel Biocare Holdings AG Description and Business Overview
    Table 73. Nobel Biocare Holdings AG Lumbosacral Radicular Pain Treatment Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of Nobel Biocare Holdings AG (2019-2024)
    Table 75. Nobel Biocare Holdings AG Recent Developments
    Table 76. Eli Lilly & Company Basic Information List
    Table 77. Eli Lilly & Company Description and Business Overview
    Table 78. Eli Lilly & Company Lumbosacral Radicular Pain Treatment Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of Eli Lilly & Company (2019-2024)
    Table 80. Eli Lilly & Company Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Lumbosacral Radicular Pain Treatment Downstream Customers
    Table 84. Lumbosacral Radicular Pain Treatment Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Lumbosacral Radicular Pain Treatment Product Picture
    Figure 2. Global Lumbosacral Radicular Pain Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Lumbosacral Radicular Pain Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Lumbosacral Radicular Pain Treatment Report Years Considered
    Figure 5. Global Lumbosacral Radicular Pain Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Lumbosacral Radicular Pain Treatment Revenue in 2023
    Figure 7. Lumbosacral Radicular Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Oral Picture
    Figure 9. Topical Picture
    Figure 10. Global Lumbosacral Radicular Pain Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Lumbosacral Radicular Pain Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospital Pharmacy
    Figure 13. Product Picture of Retail Pharmacy
    Figure 14. Product Picture of Online Pharmacy
    Figure 15. Global Lumbosacral Radicular Pain Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Lumbosacral Radicular Pain Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Lumbosacral Radicular Pain Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Lumbosacral Radicular Pain Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Lumbosacral Radicular Pain Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Lumbosacral Radicular Pain Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Lumbosacral Radicular Pain Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Lumbosacral Radicular Pain Treatment Sales Value (%), (2019-2030)
    Figure 28. United States Lumbosacral Radicular Pain Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Lumbosacral Radicular Pain Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Lumbosacral Radicular Pain Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Lumbosacral Radicular Pain Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Lumbosacral Radicular Pain Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Lumbosacral Radicular Pain Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Lumbosacral Radicular Pain Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Lumbosacral Radicular Pain Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Lumbosacral Radicular Pain Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Lumbosacral Radicular Pain Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Lumbosacral Radicular Pain Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Lumbosacral Radicular Pain Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Lumbosacral Radicular Pain Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Lumbosacral Radicular Pain Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 49. Lumbosacral Radicular Pain Treatment Industrial Chain
    Figure 50. Lumbosacral Radicular Pain Treatment Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Codeine Drug Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-29T7546
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Codeine Painkillers Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-9E7797
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Chronic Fatigue Syndrome Drug Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-26N10475
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Biopuncture Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36O5697
Fri May 10 00:00:00 UTC 2024

Add to Cart